MedPath

Customized Registry Tool for Tracking Adherence to Clinical Guidelines for Head and Neck Cancers

Completed
Conditions
Head and Neck Neoplasms
Interventions
Other: Registry
Registration Number
NCT03546322
Lead Sponsor
University of California, San Francisco
Brief Summary

To implement and evaluate a health information technology platform designed to support the management of patients with head and neck cancer in an urban, publicly-funded outpatient setting. This is an observational study; researchers will not assign specific interventions to study participants.

Detailed Description

The investigators aim to implement and evaluate a health information technology (HIT) registry at an urban, public delivery system. The investigators will not assign specific interventions to the study participants, but rather observationally assess the effect of the HIT registry, designed to support routine medical care, on participants.

The investigators will use systems engineering methodologies to design, develop, and implement the platform. The platform will be implemented in the Otolaryngology - Head and Neck Surgery clinic that cares for patients with head and neck cancers. The study will assess patient outcomes and evaluate the time it takes for patients to progress through key treatment and post-treatment milestones before and after the HIT tool is implemented. The investigators will use models controlling for secular trend to estimate the effect of the tool on improving timely and successful completion of guideline-based care processes.

The HIT platform seeks to improve the monitoring and alerting functionality of existing systems. Specifically, it replaces paper-based systems previously used by the clinic to monitor its head and neck cancer patients. It will be implemented clinic-wide for all patients being treated for head and neck cancers. The investigators are not assigning a specific intervention to patients, but rather supporting the clinic and health system in the development of a population management platform that improves routine care processes. The platform is approved for clinical use and research by the San Francisco Health Network and the University of California, San Francisco.

The HIT platform users are clinicians who are responsible for monitoring patients with head and neck cancer and agree to partner with the investigators to improve monitoring processes. The clinicians involved may be asked to voluntarily participate in surveys, interviews, focus groups, and program evaluations. Patient medical records will be reviewed, but patients monitored on the registry will not be contacted by researchers.

Procedures are in place to monitor the registry. First, quality assurance is performed by the research team, information technology analysts, and software engineers. This includes checking that data in the platform matches source data, such as data entered in the electronic health record. In addition, the platform users are audited on a weekly basis. A data dictionary defining variables used in the platform exists and is updated as needed. Patients will be added to the registry by a clinician if they are diagnosed with head and neck cancer. The research team will support the clinicians in data analysis, although this will be performed with population-level, de-identified data. However, if unmediated adverse events are identified by the research team, the research team will alert the clinicians immediately. The HIT platform is designed to supplement, but not replace, the existing electronic health record. Data on the registry will be validated with source data and users will still engage with the source data and electronic health record as appropriate clinically and operationally.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
802
Inclusion Criteria
  • Patients with head and neck surgery monitored by the Otolaryngology - Head and Neck Surgery Clinic
Read More
Exclusion Criteria
  • N/A
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
RegistryRegistryHead and neck cancer patients monitored on registry
Primary Outcome Measures
NameTimeMethod
Workup and Treatment Planning - Primary OutcomeFrom date of diagnosis to first date of treatment, assessed up to 5 years

Time from diagnosis to initiation of treatment

Treatment - Primary Outcome5 years

Proportion of patients that complete tumor board treatment recommendations

Secondary Outcome Measures
NameTimeMethod
Loss to follow-up5 years

Proportion of patients who are lost to follow-up

Workup and Treatment Planning - Secondary Outcome #3From date of diagnosis to date of first visit with oncology clinic, assessed up to 5 years

Time from diagnosis to first visit in oncology clinics

Workup and Treatment Planning - Secondary Outcome #1From date of diagnosis to presentation at tumor board, assessed up to 5 years

Time from diagnosis to presentation at tumor board

Workup and Treatment Planning - Secondary Outcome #2From date of diagnosis to date of dental evaluation for patients undergoing radiation treatment, assessed up to 5 years

Time from diagnosis to dental evaluation

Treatment - Secondary Outcome6 weeks

Proportion of patients who complete post-treatment radiation

Trial Locations

Locations (1)

Zuckerberg San Francisco General Hospital and Trauma Center

🇺🇸

San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath